SPRC
NASD SciSparc Ltd.$1.33 ↓ -0.01 (-0.75%) Trading Down from the previous close of $1.34, $0.03 below the day’s high of $1.36
- YTD change
- -89.13%
- vs 20-day SMA
- -66.55%
- vs 200-day SMA
- -78.03%
Price ranges
Price & Performance
-4.66 (-77.80%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $34,791.10
- SPRC is down 89% since the beginning of the year
- SPRC is down 97% over the past 12 months
- SPRC is down 71% over the past 1 month
- 1% of all SPRC investors are betting against SPRC
SPRC reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -68.7%.
- Previous minute
- +$0.00
- Last hour
- -$0.01
- Last 5 days
- -66.24%
- vs 8-day SMA
- -52.82%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. The Drug Development segment focuses on cannabinoid molecules to be approved by an official regulatory authority. The Online Sales segment consists of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.